Cargando…
An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein
Prion diseases are neurodegenerative conditions characterized by the conformational conversion of the cellular prion protein (PrP(C)), an endogenous membrane glycoprotein of uncertain function, into PrP(Sc), a pathological isoform that replicates by imposing its abnormal folding onto PrP(C) molecule...
Autores principales: | Stincardini, Claudia, Massignan, Tania, Biggi, Silvia, Elezgarai, Saioa R., Sangiovanni, Valeria, Vanni, Ilaria, Pancher, Michael, Adami, Valentina, Moreno, Jorge, Stravalaci, Matteo, Maietta, Giulia, Gobbi, Marco, Negro, Alessandro, Requena, Jesús R., Castilla, Joaquín, Nonno, Romolo, Biasini, Emiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546605/ https://www.ncbi.nlm.nih.gov/pubmed/28787011 http://dx.doi.org/10.1371/journal.pone.0182589 |
Ejemplares similares
-
A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein
por: Massignan, Tania, et al.
Publicado: (2016) -
Immunopurification of Pathological Prion Protein Aggregates
por: Biasini, Emiliano, et al.
Publicado: (2009) -
In vitro replication highlights the mutability of prions
por: Vanni, Ilaria, et al.
Publicado: (2014) -
Pharmacological Agents Targeting the Cellular Prion Protein
por: Barreca, Maria Letizia, et al.
Publicado: (2018) -
A tetracationic porphyrin with dual anti-prion activity
por: Masone, Antonio, et al.
Publicado: (2023)